Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Tunney

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|August 26, 2014
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosisLaura J Sherrard, Michael M Tunney, J Stuart Elborn
Expert Review of Respiratory Medicine|August 23, 2013
The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infectionG McCaughey, Df Gilpin, Js Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2011
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditionsGerard McCaughey, Matt McKevitt, J Stuart Elborn, et al.
Expert Reviews in Molecular Medicine|April 3, 2023
<i>Fusobacterium nucleatum</i>: a novel immune modulator in breast cancer?Alexa Little, Mark Tangney, Michael M Tunney, et al.
The European Respiratory Journal|June 11, 2026
Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapiesChristina S Thornton, Laura Schaupp, Michael M Tunney, et al.
Chest|December 13, 2016
ResponseKatherine O'Neill, J Stuart Elborn, Michael M Tunney, et al.
Plos One|August 13, 2013
Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditionsGerard McCaughey, Paul Diamond, J Stuart Elborn, et al.
Journal of Global Antimicrobial Resistance|February 9, 2024
In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasisMichael M Tunney, J Stuart Elborn, Chloe S McLaughlin, et al.
Journal of Photochemistry and Photobiology. B, Biology|September 12, 2006
Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue ORyan F Donnelly, Paul A McCarron, Michael M Tunney, et al.
ACS Applied Materials & Interfaces|March 18, 2025
Phenylboronic Acid-Modified Polyethyleneimine: A Glycan-Targeting Anti-Biofilm Polymer for Inhibiting Bacterial Adhesion to Mucin and Enhancing Antibiotic EfficacyLorcan J P Rooney, Andrew Marshall, Michael M Tunney, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|August 26, 2014
Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosisLaura J Sherrard, Michael M Tunney, J Stuart Elborn
Expert Review of Respiratory Medicine|August 23, 2013
The future of antimicrobial therapy in the era of antibiotic resistance in cystic fibrosis pulmonary infectionG McCaughey, Df Gilpin, Js Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 6, 2011
Antimicrobial activity of fosfomycin and tobramycin in combination against cystic fibrosis pathogens under aerobic and anaerobic conditionsGerard McCaughey, Matt McKevitt, J Stuart Elborn, et al.
Expert Reviews in Molecular Medicine|April 3, 2023
<i>Fusobacterium nucleatum</i>: a novel immune modulator in breast cancer?Alexa Little, Mark Tangney, Michael M Tunney, et al.
The European Respiratory Journal|June 11, 2026
Bridging the airway microbiome and targeted therapy in bronchiectasis: multi-omics insights, endotypes and emerging therapiesChristina S Thornton, Laura Schaupp, Michael M Tunney, et al.
Chest|December 13, 2016
ResponseKatherine O'Neill, J Stuart Elborn, Michael M Tunney, et al.
Plos One|August 13, 2013
Resistance development of cystic fibrosis respiratory pathogens when exposed to fosfomycin and tobramycin alone and in combination under aerobic and anaerobic conditionsGerard McCaughey, Paul Diamond, J Stuart Elborn, et al.
Journal of Global Antimicrobial Resistance|February 9, 2024
In vitro activity of cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasisMichael M Tunney, J Stuart Elborn, Chloe S McLaughlin, et al.
Journal of Photochemistry and Photobiology. B, Biology|September 12, 2006
Potential of photodynamic therapy in treatment of fungal infections of the mouth. Design and characterisation of a mucoadhesive patch containing toluidine blue ORyan F Donnelly, Paul A McCarron, Michael M Tunney, et al.
ACS Applied Materials & Interfaces|March 18, 2025
Phenylboronic Acid-Modified Polyethyleneimine: A Glycan-Targeting Anti-Biofilm Polymer for Inhibiting Bacterial Adhesion to Mucin and Enhancing Antibiotic EfficacyLorcan J P Rooney, Andrew Marshall, Michael M Tunney, et al.
Pageof 11